Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
cancer
Converting Cold to Hot tumors
autoimmune diseases
low-dose radiotherapy
Therapeutic opportunities of isoflavonoid compounds
antisense oligonucleotides (ASOs)
sarcoma
Health Care
Oncology
psoriasis
Septic shock
Cytokine storm
STING antagonist
Late-stage prostate cancer
RNA therapeutics
COVID-19
lupus
chronic inflammation
Interferon signaling pathway
Cytokines
Date founded
2015
Funding rounds raised
Total raised
$18M
from 1 investors over 1 rounds
N
Noxopharm Limited raised $18M on July 29, 2019
Investors: The Lind Partners, LLC